InSite Vision Incorporated - Investors - Press Releases

InSite Vision, Inc.

Press Releases

Webcast Image

Webcast
InSite Vision Incorporated at Roth Conference (Replay)
03/20/13 at 12:00 p.m. PT

Webcast Image

Webcast
Q1 2013 InSite Vision Incorporated Earnings Conference Call (Replay)
05/07/13 at 4:30 p.m. ET

Keyword Search

2013 | 2012 | 2011 | 2010 | 2009

Date	Title
05/09/13	InSite Vision Initiates Confirmatory Phase 3 Clinical Study of BromSite™ for the Reduction of Inflammation and Pain after Cataract Surgery
05/07/13	InSite Vision Reports First Quarter 2013 Financial Results
04/29/13	InSite Vision to Present Five Scientific Posters at 2013 ARVO Meeting
04/29/13	InSite Vision to Report First Quarter 2013 Financial Results on May 7, 2013
04/02/13	InSite Vision Announces Sale of Besivance® Royalty for $15 Million Plus a $1 Million Potential Milestone in Early 2014
03/27/13	Gholam A. Peyman, M.D., Joins InSite Vision's Scientific Advisory Board
03/26/13	InSite Vision Wins Appeal of Patent Interference Litigation Against the University of California, San Francisco
03/25/13	InSite Vision Completes DOUBle Phase 3 Clinical Study of AzaSite Plus™ and DexaSite™ for the Treatment of Blepharitis
03/18/13	InSite Vision Announces Positive Phase 3 Results for BromSite™ (ISV-303) for the Reduction of Inflammation and Pain after Cataract Surgery
03/11/13	InSite Vision to Present at the 25th Annual ROTH Conference
03/06/13	InSite Vision Announces Date for Annual Shareholder Meeting
03/05/13	InSite Vision Reports Fourth Quarter and Full-Year 2012 Financial Results
02/19/13	InSite Vision to Report Fourth Quarter and Year-End 2012 Financial Results on March 5, 2013
01/10/13	InSite Vision Completes Phase 3 Clinical Study of BromSite for the Reduction of Pain and Inflammation After Cataract Surgery